TRINITY BIOTECH PLC (TRIB) Gross margin 2015–2024
TRINITY BIOTECH PLC (TRIB) gross margin by fiscal year — reported gross profit divided by reported revenue.
34.8%FY2024 · since FY2015: 46.4% → 34.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | 34.8% | +0.6 pp |
| FY2023 | 34.2% | +6.6 pp |
| FY2022 | 27.6% | -13.6 pp |
| FY2021 | 41.2% | -6.4 pp |
| FY2020 | 47.6% | +5.5 pp |
| FY2019 | 42.2% | -0.6 pp |
| FY2018 | 42.7% | +0.5 pp |
| FY2017 | 42.3% | -1.4 pp |
| FY2016 | 43.7% | -2.8 pp |
| FY2015 | 46.4% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More TRIB financial trends
TRIB RevenueTRIB Net incomeTRIB Net marginTRIB Gross profitTRIB Operating incomeTRIB Operating marginTRIB Operating cash flowTRIB Free cash flowTRIB Capital expendituresTRIB Return on equityTRIB Stock buybacksTRIB Dividends paidTRIB Total assetsTRIB Total liabilitiesTRIB Shareholders’ equityTRIB overview →